Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Dominic B. Fee MD

Vice Chair, Professor

Institution: Medical College of Wisconsin
Department: Neurology
Division: General
Program: Neuromuscle

Member of the Wisconsin Institute of NeuroScience (WINS)

Publications (40)

  • Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. (Quintana M, Saville BR, Vestrucci M, Detry MA, Chibnik L, Shefner J, Berry JD, Chase M, Andrews J, Sherman AV, Yu H, Drake K, Cudkowicz M, Paganoni S, Macklin EA, HEALEY ALS Platform Trial Study Group) Ann Neurol 2023 Sep;94(3):547-560 PMID: 37245090 SCOPUS ID: 2-s2.0-85163197066 05/28/2023       4 Citations
  • Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development (Paganoni S, Berry JD, Quintana M, Macklin E, Saville BR, Detry MA, Chase M, Sherman AV, Yu H, Drake K, Andrews J, Shefner J, Chibnik LB, Vestrucci M, Cudkowicz ME, Macklin E, Quintana M, Saville BR, Detry MA, Chibnik LB, Bind MA, Chan J, Vestrucci M, Locatelli E, Alameda G, Paganoni S, Cudkowicz ME, McCaffrey A, Berry J, Babu S, Nicholson K, Scalia J, Simmons Z, Grogan J, Su X, Mamarabadi M, Heitzman D, Nasri MA, Katz J, Jenkins L, Felice K, Whitaker C, Ajroud-Driss S, Quick A, Kolb S, Sarah Heintzman NP, Appel SH, Greene E, Thonhoff J, Shroff S, Liao B, Goutman SA, Feldman EL, Miller T, Amber Malcolm NP, Newman DS, Arcila-Londono X, Steijlen K, Owegi MA, Brown RH, Ghasemi M, Fernandes JAM, Piccione E, Thaisetthawatkul P, Weiss MD, Rad N, Ilieva H, Pasinelli P, Judith Guarnieri NP, Ladha S, Jacobsen B, Bowser R, Shefner J, Foster L, Jackson C, Rosenfeld J, Bhuvaneswaran K, Elman L, Quinn C, Julia Yasek NP, Fee D, Heiman-Patterson T, Deboo A, Swenson A, Nance C, Vu T, Suresh N, Farias J, Caress J, Cartwright M, Rezania K, Elliott M, Rutkove S, McIlduff C, Cohen JA, Stommel E, Glass J, Fournier C, Young E, Wymer JP) Annals of Neurology 01 February 2022;91(2):165-175 SCOPUS ID: 2-s2.0-85122780992 02/01/2022       39 Citations
  • Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial (Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A, Kiernan M, Mathers S, Henderson R, Needham M, Schultz D, Löscher W, Mitrovic N, Rath J, Damme PV, De Bleecker JL, Delstanche S, Johnston W, Zinman L, O'Connell C, Matte G, Dionne A, Korngut L, Turnbull J, Laaksovirta H, Jokela M, Tapiola T, Soriani MH, Couratier P, Camu W, Corcia P, Ludolph A, Großkreutz J, Meyer T, Boentert M, Schrank B, Prudlo J, Untucht R, Hardiman O, Siciliano G, Chio' A, Mazzini L, Inghilleri M, Caponnetto C, Mora G, Mora Pardina JS, Farrero Munoz E, Vázquez Costa JF, Aguera Morales E, Varona L, Andersen P, Ingre C, Johansson R, Radunovic A, Young C, Babu S, Shaibani A, Staff N, Vu T, Rivner M, Scelsa S, Sivakumar K, Waheed W, Heitzman D, Rana S, Pattee G, Ajroud-Driss S, Bayat E, Kasarskis E, Lange DJ, Elliott M, Harris B, Felice K, Pulley MT, Kwan J, Brown M, Ravits J, Burford M, Karam C, Miller T, Andrews J, Levine T, Locatelli E, Wymer J, Bedlack R, Fee D, Goyal N, Oskarsson B, McCluskey L, Caress J, Weiss M, Quick A, Bromberg M, Lacomis D, Goutman S, Rezania K) The Lancet Neurology October 2021;20(10):821-831 SCOPUS ID: 2-s2.0-85114911882 10/01/2021       10 Citations
  • A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. (Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, Cockroft BM, Meng L, Wei J, Wolff AA, Malik FI, Bodkin C, Brooks BR, Caress J, Dionne A, Fee D, Goutman SA, Goyal NA, Hardiman O, Hayat G, Heiman-Patterson T, Heitzman D, Henderson RD, Johnston W, Karam C, Kiernan MC, Kolb SJ, Korngut L, Ladha S, Matte G, Mora JS, Needham M, Oskarsson B, Pattee GL, Pioro EP, Pulley M, Quan D, Rezania K, Schellenberg KL, Schultz D, Shoesmith C, Simmons Z, Statland J, Sultan S, Swenson A, Berg LHVD, Vu T, Vucic S, Weiss M, Whyte-Rayson A, Wymer J, Zinman L, Rudnicki SA) Amyotroph Lateral Scler Frontotemporal Degener 2021 May;22(3-4):287-299 PMID: 32969758 PMCID: PMC8117790 SCOPUS ID: 2-s2.0-85091435875 09/25/2020       40 Citations
  • Skill, confidence and support: conceptual elements of a child/youth caregiver training program in amyotrophic lateral sclerosis - the YCare protocol. (Kavanaugh MS, Cho Y, Fee D, Barkhaus PE) Neurodegener Dis Manag 2020 Aug;10(4):231-241 PMID: 32749175 SCOPUS ID: 2-s2.0-85095932496 08/05/2020       6 Citations
  • Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome. (Čierny M, Hooshmand SI, Fee D, Tripathi S, Dsouza NR, La Pean Kirschner A, Zimmermann MT, Brennan R) Parkinsonism Relat Disord 2020 Aug;77:110-113 PMID: 32712562 SCOPUS ID: 2-s2.0-85088215494 07/28/2020       6 Citations
  • US data on children and youth caregivers in amyotrophic lateral sclerosis. (Kavanaugh MS, Cho CC, Howard M, Fee D, Barkhaus PE) Neurology 2020 Apr 07;94(14):e1452-e1459 PMID: 32188763 SCOPUS ID: 2-s2.0-85086092455 03/20/2020       10 Citations
  • Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis. (Seminary ER, Santarriaga S, Wheeler L, Mejaki M, Abrudan J, Demos W, Zimmermann MT, Urrutia RA, Fee D, Barkhaus PE, Ebert AD) Cells 2020 Feb 28;9(3) PMID: 32121108 PMCID: PMC7140469 SCOPUS ID: 2-s2.0-85092221701 03/04/2020       10 Citations
  • Generation and propagation of the action potential. (Raghavan M, Fee D, Barkhaus PE) Handb Clin Neurol 2019;160:3-22 PMID: 31277855 SCOPUS ID: 2-s2.0-85068161532 07/07/2019       25 Citations
  • Siblings With Mutations in TRAPPC11 Presenting With Limb-Girdle Muscular Dystrophy 2S. (Fee DB, Harmelink M, Monrad P, Pyzik E) J Clin Neuromuscul Dis 2017 Sep;19(1):27-30 PMID: 28827486 SCOPUS ID: 2-s2.0-85028630388 08/23/2017       23 Citations
  • Ordering multigene testing in polyneuropathy. (Fee D, Marques W Jr) Neurology 2016 May 10;86(19):1752-3 PMID: 27164710 SCOPUS ID: 2-s2.0-84978438170 05/11/2016       1 Citation
  • Neurological effects of arsenic exposure (Fee DB) Arsenic: Exposure Sources, Health Risks, and Mechanisms of Toxicity 30 October 2015:193-219 SCOPUS ID: 2-s2.0-85018925326 10/30/2015       4 Citations
  • Elderly onset of weakness in facioscapulohumeral muscular dystrophy. (Fee DB) Case Rep Neurol Med 2012;2012:726984 PMID: 23024867 PMCID: PMC3457597 10/02/2012    
  • External neurolysis may result in early return of function in some muscle groups following brachial plexus surgery. (Swartz KR, Boland M, Fee DB) Clin Neurol Neurosurg 2012 Jul;114(6):768-75 PMID: 22269646 SCOPUS ID: 2-s2.0-84862011019 01/25/2012       6 Citations
  • Letter to the Editor. (Spinner RJ, Hébert-Blouin MN, Tanaka S, Amrami KK, Swartz KR, Fee DB, Sugita M) J Neurosurg 2011 Apr 29: PMID: 21529206 05/03/2011    
  • Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. (Espinosa PS, Bensalem-Owen MK, Fee DB) Clin Neurol Neurosurg 2010 Jul;112(6):537-40 PMID: 20430517 SCOPUS ID: 2-s2.0-77952887690 05/01/2010       30 Citations
  • Melatonin-analog, beta-methyl-6-chloromelatonin, supplementation in spinal cord injury. (Fee DB, Swartz KR, Scheff N, Roberts K, Gabbita P, Scheff S) Brain Res 2010 Jun 22;1340:81-5 PMID: 20420812 SCOPUS ID: 2-s2.0-77953121482 04/28/2010       8 Citations
  • Hip- and pelvic-related intraneural ganglia. (Spinner RJ, Hébert-Blouin MN, Tanaka S, Amrami KK, Swartz KR, Fee DB, Sugita M) J Neurosurg 2010 Jun;112(6):1353-6 PMID: 20415528 SCOPUS ID: 2-s2.0-77953483919 04/27/2010       8 Citations
  • Proximal sciatic nerve intraneural ganglion cyst. (Swartz KR, Wilson D, Boland M, Fee DB) Case Rep Med 2009;2009:810973 PMID: 20069041 PMCID: PMC2797755 01/14/2010    
  • Arsenic (Fee DB) Clinical Neurotoxicology: Syndromes, Substances, Environments 2009:273-276 SCOPUS ID: 2-s2.0-84884103521 12/01/2009       1 Citation
  • Exacerbation of spinal cord injury due to static compression occurring early after onset. (Swartz KR, Scheff NN, Roberts KN, Fee DB) J Neurosurg Spine 2009 Nov;11(5):570-4 PMID: 19929360 SCOPUS ID: 2-s2.0-71849093994 11/26/2009       13 Citations
  • Response (Swartz KR, Fee DB) Journal of Neurosurgery: Spine November 2009;11(5):569 SCOPUS ID: 2-s2.0-71849088787 11/01/2009    
  • Arsenic (Fee DB) Clinical Neurotoxicology: Syndromes, Substances, Environments, Expert Consult - Online and Print 18 June 2009:273-276 SCOPUS ID: 2-s2.0-85134241465 06/18/2009    
  • Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness. (Berger JR, Fee DB, Nelson P, Nuovo G) J Neurovirol 2009 May;15(3):282-7 PMID: 19444695 SCOPUS ID: 2-s2.0-70450227353 05/16/2009       8 Citations
  • Myasthenia gravis associated with etanercept therapy. (Fee DB, Kasarskis EJ) Muscle Nerve 2009 Jun;39(6):866-70 PMID: 19373885 SCOPUS ID: 2-s2.0-67049145696 04/18/2009       52 Citations
  • Monitoring during total hip arthroplasty (Fee D, Sabet A) Handbook of Clinical Neurophysiology 2008;8(C):748-751 SCOPUS ID: 2-s2.0-77957091552 12/01/2008    
  • Kümmell's disease: a case report and literature review. (Swartz K, Fee D) Spine (Phila Pa 1976) 2008 Mar 01;33(5):E152-5 PMID: 18317183 SCOPUS ID: 2-s2.0-41049115200 03/05/2008       60 Citations
  • Diabetic muscle infarction: a poorly understood, rare complication of long-standing diabetes mellitus. (Fee D, Waclawik A) J Ky Med Assoc 2007 Oct;105(10):485-90 PMID: 18038510 SCOPUS ID: 2-s2.0-38449103008 11/28/2007       1 Citation
  • Gender differences in spinal cord injury are not estrogen-dependent. (Swartz KR, Fee DB, Joy KM, Roberts KN, Sun S, Scheff NN, Wilson ME, Scheff SW) J Neurotrauma 2007 Mar;24(3):473-80 PMID: 17402853 SCOPUS ID: 2-s2.0-34247166204 04/04/2007       57 Citations
  • Effects of progesterone on experimental spinal cord injury. (Fee DB, Swartz KR, Joy KM, Roberts KN, Scheff NN, Scheff SW) Brain Res 2007 Mar 16;1137(1):146-52 PMID: 17204255 SCOPUS ID: 2-s2.0-33846906034 01/06/2007       44 Citations
  • Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. (Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, Mock AF, Evidente VG, Fee DB, Müller U, Dürr A, Brice A, Papazian DM, Pulst SM) Nat Genet 2006 Apr;38(4):447-51 PMID: 16501573 SCOPUS ID: 2-s2.0-33645421783 02/28/2006       254 Citations
  • An autosomal dominant ataxia maps to 19q13: Allelic heterogeneity of SCA13 or novel locus? (Waters MF, Fee D, Figueroa KP, Nolte D, Müller U, Advincula J, Coon H, Evidente VG, Pulst SM) Neurology 2005 Oct 11;65(7):1111-3 PMID: 16135769 SCOPUS ID: 2-s2.0-26444545060 09/02/2005       35 Citations
  • Phenotypic variability associated with Arg26Gln mutation in caveolin3. (Fee DB, So YT, Barraza C, Figueroa KP, Pulst SM) Muscle Nerve 2004 Sep;30(3):375-8 PMID: 15318349 SCOPUS ID: 2-s2.0-4243061710 08/20/2004       30 Citations
  • Traumatic brain injury increases TGF beta RII expression on endothelial cells. (Fee DB, Sewell DL, Andresen K, Jacques TJ, Piaskowski S, Barger BA, Hart MN, Fabry Z) Brain Res 2004 Jun 25;1012(1-2):52-9 PMID: 15158160 SCOPUS ID: 2-s2.0-2442480252 05/26/2004       27 Citations
  • Blossoming traumatic epidural hematoma. (Swartz KR, Fee DB, Dempsey RJ) J Emerg Med 2003 Nov;25(4):451-2 PMID: 14654189 SCOPUS ID: 2-s2.0-0345275957 12/05/2003    
  • Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. (Fee DB, Fleming JO) J Peripher Nerv Syst 2003 Sep;8(3):155-8 PMID: 12904236 SCOPUS ID: 2-s2.0-0043193865 08/09/2003       14 Citations
  • Unilateral calf hypertrophy seen in lumbosacral stenosis: case report and review of the literature. (Swartz KR, Fee DB, Trost GR, Waclawik AJ) Spine (Phila Pa 1976) 2002 Sep 15;27(18):E406-9 PMID: 12634577 SCOPUS ID: 2-s2.0-18544410599 03/14/2003       16 Citations
  • Activated/effector CD4+ T cells exacerbate acute damage in the central nervous system following traumatic injury. (Fee D, Crumbaugh A, Jacques T, Herdrich B, Sewell D, Auerbach D, Piaskowski S, Hart MN, Sandor M, Fabry Z) J Neuroimmunol 2003 Mar;136(1-2):54-66 PMID: 12620643 SCOPUS ID: 2-s2.0-0037333903 03/07/2003       92 Citations
  • Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. (Fee D, Grzybicki D, Dobbs M, Ihyer S, Clotfelter J, Macvilay S, Hart MN, Sandor M, Fabry Z) Cytokine 2000 Jun;12(6):655-65 PMID: 10843741 SCOPUS ID: 2-s2.0-0033947016 06/14/2000       90 Citations
  • TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. (Fabry Z, Topham DJ, Fee D, Herlein J, Carlino JA, Hart MN, Sriram S) J Immunol 1995 Jul 01;155(1):325-32 PMID: 7602108 SCOPUS ID: 2-s2.0-0028982243 07/01/1995       91 Citations
    • Last update: 09/22/2023